GFH009: A Potent and Highly Selective CDK9 Inhibitor for the Treatment of Hematologic Malignancies
December 27, 2023
the results of this preclinical investigation program suggest that induction of apoptosis is a key component of GFH009’s anti-tumor mechanism of action [...]”BUFFALO, NY- December 27, 2023 – A new... read more